This podcast, Part 3 of a 3-part series on thyroid eye disease (TED), examines the multidisciplinary management of TED with a focus on teprotumumab-associated adverse effects. Through expert discussions and case-based examples, listeners will learn best practices for managing hyperglycemia, hearing changes, and other potential complications. The session outlines the essential role of primary eye care professionals in comanaging TED, from early recognition to educating patients and coordinating care with specialists. Clinicians will be equipped to apply collaborative strategies to optimize outcomes for TED patients.